RLAY

Relay Therapeutics, Inc. Common Stock

17.98

USD

+0.10

+0.56%

Oct 12, 15:59 UTC -4

Closed

After-Market

18.15

+0.17

+0.95%

Relay Therapeutics, Inc. Common Stock Profile

About

Relay Therapeutics Inc. is a clinical-stage precision medicines company. It focuses on enhancing small molecule therapeutic discovery in targeted oncology. The company's product pipeline consist RLY-1971, RLY-4008 and RLY-PI3K1047 which are in clinical stage. Relay Therapeutics Inc. is based in Cambridge, Massachusetts.

Info & Links

CEO

Sanjiv K. Patel

Headquarters

60 HAMPSHIRE STREET
CAMBRIDGE, MA 02139, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

192

Relay Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

3.98B

Enterprise Value

3.86B

Enterprise Value/EBITDA(ttm)

-12.38

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

3.85

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

Profit Margin(ttm)

-6785.89%

Return on Equity(ttm)

-42.27%

Return on Invested Capital(ttm)

-42.70%

Return on Assets(ttm)

-38.67%

Income Statement

Revenue(ttm)

10.35M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

10.35M

EBITDA(ttm)³

-311.59M

Net Income Available to Common(ttm)

-286.04M

Diluted EPS(ttm)

-1.57

Share Statistics

Beta (5Y Monthly)

1.72

52-Week Change

176.62%

S&P 500 52-Week Change

21.06%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

219.14M

Dividend Yield

0.00%

Float⁴

208.10M

% Held by Insiders

5.04%

% Held by Institutions

96.98%

Balance Sheet

Total Cash(mrq)

910.93M

Total Cash Per Share(mrq)

4.16

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

18.27%

Quick Ratio(mrq)

18.27%

Book Value Per Share(mrq)

4.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.52

Free Cash Flow(ytd)

-105.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.